Equities

Vijaya Diagnostic Centre Ltd

VIJAYA:NSI

Vijaya Diagnostic Centre Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)793.50
  • Today's Change-13.35 / -1.65%
  • Shares traded292.37k
  • 1 Year change+95.68%
  • Beta--
Data delayed at least 15 minutes, as of Jun 14 2024 11:12 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vijaya Diagnostic Centre Limited is an India-based company. The Company is engaged in the business of providing comprehensive range of diagnostic services, spanning pathological investigations, basic and high-end radiology, nuclear medicine, and related healthcare services. The Company operates through the Diagnostic Services segment. Its services include clinical pathology, microbiology, hematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, computerized tomography (CT) scan, magnetic resonance imaging (MRI) scan, ultrasound, x-ray, cardiology, gastroenterology, nuclear medicine, pet CT, and MRI -3t. It operates approximately 121 diagnostic centers in 20 cities spread across India.

  • Revenue in INR (TTM)5.48bn
  • Net income in INR1.19bn
  • Incorporated2002
  • Employees2.00k
  • Location
    Vijaya Diagnostic Centre Ltd3-6-16 & 17, Street No. 19, HimayatnagarHYDERABAD 500082IndiaIND
  • Phone+91 4 023420411
  • Fax+91 4 023425087
  • Websitehttps://www.vijayadiagnostic.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
VIJAYA:NSI since
announced
Transaction
value
Ph Diagnostic Centre Pvt LtdAnnounced19 Dec 202319 Dec 2023Announced28.81%16.20m
Data delayed at least 15 minutes, as of Jun 14 2024 11:12 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Krsnaa Diagnostics Ltd6.20bn568.40m21.52bn2.56k38.252.6616.383.4717.4217.42190.03250.790.59534.634.97--5.466.726.688.5977.2482.559.1711.741.374.230.1648--27.2024.25-8.49--14.21--
Indraprastha Medical Corporation Ltd12.45bn1.24bn22.58bn2.95k18.224.7313.771.8113.5213.52135.7652.121.9566.2219.66--19.3912.7425.2117.0457.4957.379.966.731.8237.750.066429.1313.299.5743.8934.2632.3422.98
Artemis Medicare Services Ltd8.79bn491.41m24.62bn1.94k50.795.4927.522.803.543.5463.0232.750.93640.009.20--5.24--6.66------5.594.590.92082.950.4133--19.149.9627.3219.12----
Shalby Ltd9.34bn840.80m30.60bn2.68k36.703.0622.543.287.787.7886.2193.330.64642.407.44--5.784.827.065.5345.9063.928.948.200.98087.780.272719.1216.0115.1024.1921.578.3919.14
Thyrocare Technologies Ltd5.72bn707.70m34.59bn1.65k48.716.5629.686.0513.4113.41108.0899.520.89594.438.89--10.8918.1712.5520.9770.8569.8112.1519.562.5526.830.074383.568.587.269.94-3.638.88-2.09
Yatharth Hospital & Trauma Cre Srvcs Ltd6.70bn1.14bn36.64bn--27.734.1925.485.4715.3915.3991.17101.84----------11.27--13.7380.1478.5017.0812.307.4741.510.0883--28.8845.7874.0695.813.69--
Healthcare Global Enterprises Ltd19.08bn481.40m54.50bn5.50k114.076.6025.272.863.433.43136.1259.290.759621.966.40--1.65-2.262.26-3.0553.4053.782.17-3.500.85681.390.5956--12.8014.3564.03--0.0453--
Jupiter Life Line Hospitals Ltd10.70bn1.77bn81.31bn3.14k43.296.9637.137.6028.6528.65171.06178.300.94369.3920.79--15.58--17.39--82.28--16.51--3.677.430.00--19.83--142.25------
Vijaya Diagnostic Centre Ltd5.48bn1.19bn81.35bn2.00k68.4612.3646.0514.8511.5911.5953.4464.210.596718.1042.58--13.0314.1014.1415.5488.0586.4121.8421.202.836.830.2826.6619.3413.3740.4020.977.58--
Metropolis Healthcare Ltd12.08bn1.28bn100.32bn4.29k78.719.1545.008.3124.8824.88235.10213.970.79026.159.73--8.4013.6510.1116.9478.7975.7310.6414.661.138.350.152--5.189.67-10.541.2521.84--
Rainbow Children's Medicare Ltd12.97bn2.17bn132.96bn3.58k61.2710.5640.2510.2521.3821.38127.78124.030.65817.7321.29--11.089.8911.9910.9687.2683.5116.8313.804.005.360.377--10.5119.032.9337.2332.22--
Data as of Jun 14 2024. Currency figures normalised to Vijaya Diagnostic Centre Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

32.49%Per cent of shares held by top holders
HolderShares% Held
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 May 20246.37m6.22%
Abrdn Asia Ltd.as of 13 Jun 20245.82m5.68%
Wasatch Advisors LPas of 31 Mar 20245.37m5.24%
Mirae Asset Investment Managers (India) Pvt Ltd.as of 31 May 20243.61m3.52%
Kotak Mahindra Asset Management Co. Ltd.as of 31 May 20243.27m3.19%
Axis Asset Management Co. Ltd.as of 31 May 20243.08m3.01%
Al Mehwar Commercial Investments LLCas of 31 Mar 20243.06m2.99%
DSP Asset Managers Pvt. Ltd.as of 31 May 20241.02m0.99%
Motilal Oswal Asset Management Co. Ltd.as of 31 May 2024915.04k0.89%
ODIN Forvaltning ASas of 31 May 2024790.00k0.77%
More ▼
Data from 31 Mar 2024 - 13 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.